Christopher B Prentiss Insider Trading $ADMS Adamas Pharmaceuticals Inc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Christopher B Prentiss.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Christopher B Prentiss. Christopher B Prentiss is Chief Accounting Officer in Adamas Pharmaceuticals Inc ($ADMS) and Chief Financial Officer in Adamas Pharmaceuticals Inc ($ADMS).
Christopher B Prentiss in Adamas Pharmaceuticals Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Christopher B Prentiss: Chief Financial Officer, Chief Accounting Officer
Holdings: 145,017 shares
Current Value: $2,343,475
Latest Transaction: Mar 23 2021
$ADMS Market Capitalization: $364.02M
$ADMS Previous Close: $16.16
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Christopher B Prentiss in Adamas Pharmaceuticals Inc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23 2021 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Financial Off ... | Sell | S | 5.48 | 2,422 | 13,273 | 145,017 | 147.4 K to 145 K (-1.64 %) |
| Mar 03 2021 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Financial Off ... | Grant | A | 0.00 | 75,000 | 0 | 147,439 | 72.4 K to 147.4 K (+103.54 %) |
| Feb 01 2021 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Financial Off ... | Sell | S | 6.36 | 3,821 | 24,302 | 72,439 | 76.3 K to 72.4 K (-5.01 %) |
| Jan 22 2021 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Financial Off ... | Sell | S | 4.41 | 2,630 | 11,598 | 76,260 | 78.9 K to 76.3 K (-3.33 %) |
| Nov 02 2020 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Financial Off ... | Sell | S | 3.21 | 2,050 | 6,581 | 78,890 | 80.9 K to 78.9 K (-2.53 %) |
| Nov 02 2020 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Financial Off ... | Sell | S | 3.21 | 2,050 | 6,581 | 78,890 | 80.9 K to 78.9 K (-2.53 %) |
| Mar 19 2020 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Financial Off ... | Grant | A | 0.00 | 10,000 | 0 | 80,940 | 70.9 K to 80.9 K (+14.10 %) |
| Jan 23 2020 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Financial Off ... | Sell | S | 5.92 | 1,269 | 7,512 | 70,940 | 72.2 K to 70.9 K (-1.76 %) |
| Nov 08 2019 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Financial Off ... | Option Exercise | A | 4.70 | 50,000 | 235,000 | 50,000 | |
| Nov 08 2019 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Financial Off ... | Grant | A | 0.00 | 25,000 | 0 | 72,209 | 47.2 K to 72.2 K (+52.96 %) |
| Jul 23 2019 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Accounting Of ... | Sell | S | 6.00 | 1,082 | 6,492 | 47,209 | 48.3 K to 47.2 K (-2.24 %) |
| Apr 10 2019 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Accounting Of ... | Option Exercise | A | 6.81 | 37,500 | 255,375 | 37,500 | |
| Apr 10 2019 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Accounting Of ... | Grant | A | 0.00 | 18,750 | 0 | 48,291 | 29.5 K to 48.3 K (+63.47 %) |
| Mar 21 2019 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Accounting Of ... | Sell | S | 8.00 | 1,185 | 9,480 | 29,541 | 30.7 K to 29.5 K (-3.86 %) |
| Dec 28 2018 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Accounting Of ... | Grant | A | 0.00 | 12,500 | 0 | 30,726 | 18.2 K to 30.7 K (+68.58 %) |
| Dec 26 2018 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Accounting Of ... | Sell | S | 7.51 | 228 | 1,712 | 18,226 | 18.5 K to 18.2 K (-1.24 %) |
| Mar 22 2018 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Accounting Of ... | Sell | S | 25.98 | 567 | 14,731 | 17,758 | 18.3 K to 17.8 K (-3.09 %) |
| Mar 09 2018 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Accounting Of ... | Option Exercise | A | 25.66 | 30,000 | 769,800 | 30,000 | |
| Mar 09 2018 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Accounting Of ... | Grant | A | 0.00 | 5,000 | 0 | 18,325 | 13.3 K to 18.3 K (+37.52 %) |
| Oct 10 2017 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Accounting Of ... | Option Exercise | A | 23.11 | 15,000 | 346,650 | 15,000 | |
| Oct 10 2017 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Accounting Of ... | Grant | A | 0.00 | 2,500 | 0 | 12,405 | 9.9 K to 12.4 K (+25.24 %) |
Page: 1